This brand name is authorized in France, Tunisia
The drug ALDACTAZINE contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Spironolactone
UNII 27O7W4T232 - SPIRONOLACTONE
|
|
Spironolactone, as a competitive aldosterone antagonist, increases sodium excretion whilst reducing potassium loss at the distal renal tubule. It has a gradual and prolonged action. |
|
2
Altizide
UNII GI8CB72B0D - ALTHIAZIDE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C03EA04 | Altizide and potassium-sparing agents | C Cardiovascular system → C03 Diuretics → C03E Diuretics and potassium-sparing agents in combination → C03EA Low-ceiling diuretics and potassium-sparing agents |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 69724251 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 4133021 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
